RxDoctor Payments Data

Mildred Kinnard

Family · Newark, OHNPI 1295044626

Payments from drug & device makers

$808in general payments, 2019–2025

Across 48 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$285
  • Novo Nordisk$149
  • Astellas Pharma US Inc$91
  • Merck$58
  • AstraZeneca$55
  • Abbott$42
  • plus $127 from 6 others

What the payments were for

  • Food & beverage$808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$808 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$40,165
Medicare patients
170
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$57,368
EliquisApixaban43$44,611
TrulicityDulaglutide28$37,195
FarxigaDapagliflozin Propanediol28$31,153
JardianceEmpagliflozin18$24,152
JanuviaSitagliptin Phosphate17$22,716
Tresiba Flextouch U-100Insulin Degludec24$11,844
MounjaroTirzepatide11$10,832
SymbicortBudesonide/Formoterol Fumarate24$10,382
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,357
Albuterol Sulfate HfaAlbuterol Sulfate117$4,133
VascepaIcosapent Ethyl18$4,119
Atorvastatin Calcium347$3,435
Carbamazepine ErCarbamazepine14$2,519
SynthroidLevothyroxine Sodium37$2,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$149$57,36857 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$55$48,89264 claims
Lilly USA, LLCTrulicity, Mounjaro$18$48,02739 claims
PfizerEliquis$28$44,61143 claims
MerckJanuvia$58$22,71617 claims
AbbVieSynthroid$285$2,43837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in Newark

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →